Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00657878
What this trial is testing

Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 215
Not applicableUnknownNCT02516540
What this trial is testing

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer
Technical University of Munich 600
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00239980
What this trial is testing

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Who this might be right for
Ovarian Cancer
Ontario Clinical Oncology Group (OCOG) 77
Testing effectiveness (Phase 2)Looking for participantsNCT06677190
What this trial is testing

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Who this might be right for
Ovarian CancerOvarian CarcinomaEndometrial Cancer+5 more
Dana-Farber Cancer Institute 32
Not applicableStudy completedNCT01549925
What this trial is testing

Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand

Who this might be right for
Epithelial Ovarian Cancer
University of Utah 50
Not applicableStudy completedNCT02529150
What this trial is testing

WISER After Ovarian Cancer - Exercise Pilot Study

Who this might be right for
Ovarian Cancer
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00479817
What this trial is testing

Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Amgen 161
Not applicableStudy completedNCT04460768
What this trial is testing

An INternational Frontline Ovarian Cancer Real World Management Study

Who this might be right for
Ovarian Neoplasms
AstraZeneca 989
Testing effectiveness (Phase 2)Looking for participantsNCT05610735
What this trial is testing

Combination Therapy for Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Sham Sunder Kakar 72
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Study completedNCT01824615
What this trial is testing

Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian CancerAdverse Effects
Cathay General Hospital 30
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Testing effectiveness (Phase 2)Study completedNCT00002474
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Loyola University
Testing effectiveness (Phase 2)Study completedNCT00937560
What this trial is testing

First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 190
Large-scale testing (Phase 3)UnknownNCT06211023
What this trial is testing

SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 520
Testing effectiveness (Phase 2)Study completedNCT00345540
What this trial is testing

Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Cellectar Biosciences, Inc. 15
Early research (Phase 1)Looking for participantsNCT05172310
What this trial is testing

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Who this might be right for
Pancreatic NeoplasmsStomach NeoplasmsBile Duct Neoplasms+1 more
Karolinska University Hospital 410
Large-scale testing (Phase 3)Active Not RecruitingNCT03842982
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)

Who this might be right for
Ovary NeoplasmsOvarian CancerOvarian Carcinoma
Centre Oscar Lambret 362
Not applicableNot Yet RecruitingNCT06541171
What this trial is testing

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

Who this might be right for
Ovarian CancerRecurrent Ovarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 220
Next Page